Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients
Clinical trial NCT02654041 · TERMINATED
Trial details
- NCT number
- NCT02654041
- Sponsor
- Musli Thyropeutics Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-06-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.